U.S., Oct. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07203677) titled 'Comparative Effectiveness of Tirzepatide Versus Sitagliptin in Individuals at Cardiovascular Risk (TIRZSITA-CVOT)' on Sept. 25.
Brief Summary: Investigators are building an empirical evidence base for real world data through large-scale emulation of randomized controlled trials. The investigators' goal is to understand for what types of clinical questions real world data analyses can be conducted with confidence and how to implement such studies.
Study Start Date: Sept. 19
Study Type: OBSERVATIONAL
Condition:
Type2 Diabetes Mellitus
Atherosclerotic Cardiovascular Disease
Intervention:
DRUG: Initiation of tirzepatide
New use of...